185 related articles for article (PubMed ID: 19184362)
1. Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis.
Anderson GD; Keys KL; De Ciechi PA; Masferrer JL
Inflamm Res; 2009 Feb; 58(2):109-17. PubMed ID: 19184362
[TBL] [Abstract][Full Text] [Related]
2. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
3. The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
Nickerson-Nutter CL; Medvedeff ED
Arthritis Rheum; 1996 Mar; 39(3):515-21. PubMed ID: 8607901
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective COX-2 and 5-LOX inhibition on prostaglandin and leukotriene synthesis in ductal pancreatic cancer in Syrian hamster.
Gregor JI; Kilian M; Heukamp I; Kiewert C; Kristiansen G; Schimke I; Walz MK; Jacobi CA; Wenger FA
Prostaglandins Leukot Essent Fatty Acids; 2005 Aug; 73(2):89-97. PubMed ID: 15964750
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
[TBL] [Abstract][Full Text] [Related]
6. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice.
Ochi T; Ohkubo Y; Mutoh S
Biochem Pharmacol; 2003 Sep; 66(6):1055-60. PubMed ID: 12963493
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord.
Mi WL; Mao-Ying QL; Liu Q; Wang XW; Wang YQ; Wu GC
Brain Res Bull; 2008 Sep; 77(2-3):98-104. PubMed ID: 18721668
[TBL] [Abstract][Full Text] [Related]
8. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
[TBL] [Abstract][Full Text] [Related]
10. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Vardar S; Buduneli E; Baylas H; Berdeli AH; Buduneli N; Atilla G
J Periodontol; 2005 Jan; 76(1):99-106. PubMed ID: 15830643
[TBL] [Abstract][Full Text] [Related]
11. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
[TBL] [Abstract][Full Text] [Related]
12. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
13. Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats.
Noguchi M; Kimoto A; Sasamata M; Miyata K
J Bone Miner Metab; 2008; 26(5):461-8. PubMed ID: 18758904
[TBL] [Abstract][Full Text] [Related]
14. Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.
Mohebati A; Milne GL; Zhou XK; Duffield-Lillico AJ; Boyle JO; Knutson A; Bosworth BP; Kingsley PJ; Marnett LJ; Brown PH; Akpa EG; Szabo E; Dannenberg AJ
Cancer Prev Res (Phila); 2013 Jul; 6(7):646-55. PubMed ID: 23682075
[TBL] [Abstract][Full Text] [Related]
15. Characterization and modulation of canine mast cell derived eicosanoids.
Lin TY; London CA
Vet Immunol Immunopathol; 2010 May; 135(1-2):118-127. PubMed ID: 20036014
[TBL] [Abstract][Full Text] [Related]
16. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
[TBL] [Abstract][Full Text] [Related]
17. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
18. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
